82 related articles for article (PubMed ID: 1322862)
21. [BRCA1 associated protein 1 (BAP1) expression in pleural diffuse malignant mesothelioma: A comparative cytological and histological analyses on 50 patients].
Jaouen A; Thivolet-Bejui F; Chalabreysse L; Piaton E; Traverse-Glehen A; Isaac S; Decaussin-Petrucci M; Depaepe L; Fontaine J; Remy I; Maury JM; Brevet M
Ann Pathol; 2016 Apr; 36(2):111-9. PubMed ID: 26995100
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma with mesothelioma-like dissemination.
Otsuki Y; Shimizu S; Hosoda Y; Nagasawa M; Sato Y; Kobayashi H
Pathol Int; 2005 Nov; 55(11):738-44. PubMed ID: 16271087
[TBL] [Abstract][Full Text] [Related]
23. Utility of the antibodies CA 19-9, HBME-1, and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology.
Fetsch PA; Abati A; Hijazi YM
Cancer; 1998 Apr; 84(2):101-8. PubMed ID: 9570213
[TBL] [Abstract][Full Text] [Related]
24. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
Brown RW; Clark GM; Tandon AK; Allred DC
Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
[TBL] [Abstract][Full Text] [Related]
25. Primary intrahepatic malignant mesothelioma of epithelioid type.
Gütgemann I; Standop J; Fischer HP
Virchows Arch; 2006 May; 448(5):655-8. PubMed ID: 16541281
[TBL] [Abstract][Full Text] [Related]
26. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of membranous staining of mesothelioma.
King JA; Tucker JA
Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
[TBL] [Abstract][Full Text] [Related]
28. Four cases of cell cannibalism in highly malignant feline and canine tumors.
Ferreira FC; Soares MJ; Carvalho S; Borralho L; Vicente G; Branco S; Correia J; Peleteiro MC
Diagn Pathol; 2015 Nov; 10():199. PubMed ID: 26525147
[TBL] [Abstract][Full Text] [Related]
29. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
30. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
[TBL] [Abstract][Full Text] [Related]
31. [Histochemical observation using thrombomodulin staining method for damage of sinusoidal endothelial cells: preliminary report].
Ueno S; Kobayashi Y; Mitsue S; Tanabe G; Aiko T; Shimazu H
Nihon Geka Gakkai Zasshi; 1993 May; 94(5):538. PubMed ID: 7687322
[No Abstract] [Full Text] [Related]
32. GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.
Berg KB; Churg A
Am J Surg Pathol; 2017 Sep; 41(9):1221-1225. PubMed ID: 28614203
[TBL] [Abstract][Full Text] [Related]
33. Differentiating malignant pleural mesothelioma from pulmonary adenocarcinoma.
Gil J
Hum Pathol; 1993 Sep; 24(9):1036. PubMed ID: 8253459
[No Abstract] [Full Text] [Related]
34. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas.
Peralta Soler A; Knudsen KA; Jaurand MC; Johnson KR; Wheelock MJ; Klein-Szanto AJ; Salazar H
Hum Pathol; 1995 Dec; 26(12):1363-9. PubMed ID: 8522310
[TBL] [Abstract][Full Text] [Related]
35. Malignant mesothelioma: diagnosis by skin biopsy.
Berkowitz RK; Longley J; Buchness MR; Silvers DN; Ozzello L; Grossman ME
J Am Acad Dermatol; 1989 Nov; 21(5 Pt 2):1068-73. PubMed ID: 2530254
[TBL] [Abstract][Full Text] [Related]
36. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases.
Chu PG; Weiss LM
Mod Pathol; 2002 Jan; 15(1):6-10. PubMed ID: 11796835
[TBL] [Abstract][Full Text] [Related]
37. Mucin-positive epithelial mesothelioma and pseudomesotheliomatous adenocarcinoma.
Friedman HD; Litovsky SH; Abraham JL
Arch Pathol Lab Med; 1993 Oct; 117(10):967. PubMed ID: 8215835
[No Abstract] [Full Text] [Related]
38. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
[TBL] [Abstract][Full Text] [Related]
39. [Differential diagnosis among reactive mesothelia, adenocarcinoma and malignant mesothelioma].
Kamei T; Sakuma N
Rinsho Byori; 1999 Jul; 47(7):601-13. PubMed ID: 10442038
[TBL] [Abstract][Full Text] [Related]
40. Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma.
Khalidi HS; Medeiros LJ; Battifora H
Am J Clin Pathol; 2000 May; 113(5):649-54. PubMed ID: 10800396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
